Page last updated: 2024-10-26

ellipticine and Acute Lung Injury

ellipticine has been researched along with Acute Lung Injury in 1 studies

ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.

Acute Lung Injury: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).

Research Excerpts

ExcerptRelevanceReference
"Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF."5.56Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020)
"Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF."1.56Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, X1
Ye, C1
Mulati, M1
Sun, L1
Qian, F1

Other Studies

1 other study available for ellipticine and Acute Lung Injury

ArticleYear
Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Amylases; Animals; Anti-Inflammatory Agents

2020